IDEXX Advances the Future of Veterinary Cancer Care with Comprehensive Mast Cell Tumor Testing for Dogs
IDEXX Laboratories, Inc. (IDXX)
Last idexx laboratories, inc. earnings: 4/30 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
idexx.com/en/about-idexx/investors
Company Research
Source: Business Wire
Cancer Dx expansion and inVue Dx FNA combine preventive screening and rapid, in-clinic diagnosis, enabling veterinarians and pet owners to act with confidence WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced two major advancements in veterinary cancer diagnostics: the expansion of its IDEXX Cancer Dx™ Panel to include canine mast cell tumor detection, starting mid-year 2026 in North America, and the rollout of FNA cytology on the IDEXX inVue Dx™ Cellular Analyzer, as of late Q4 2025. Together, these innovations will deliver earlier insights and rapid, in-clinic answers, helping veterinary teams guide timely treatment decisions. With mast cell tumor and lymphoma detection, the Cancer Dx Panel will address over one-third of all canine cancer cases.1This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260115425467/en/IDEXX Cancer Dx TestingEx
Show less
Read more
Impact Snapshot
Event Time:
IDXX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IDXX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IDXX alerts
High impacting IDEXX Laboratories, Inc. news events
Weekly update
A roundup of the hottest topics
IDXX
News
- Lowest-Dose Radiography Meets Next-Level Imaging: IDEXX Launches ImageVue DR50 Plus [Yahoo! Finance]Yahoo! Finance
- Lowest-Dose Radiography Meets Next-Level Imaging: IDEXX Launches ImageVue DR50 PlusBusiness Wire
- IDEXX Laboratories (NASDAQ:IDXX) was upgraded by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from a "hold (c+)" rating to a "buy (b-)" rating.MarketBeat
- IDEXX appoints Michael Erickson as CEO [Seeking Alpha]Seeking Alpha
- IDEXX Announces CEO Succession [Yahoo! Finance]Yahoo! Finance
IDXX
Earnings
- 11/3/25 - Beat
IDXX
Sec Filings
- 1/13/26 - Form 8-K
- 12/3/25 - Form 4
- 11/10/25 - Form 4
- IDXX's page on the SEC website